Could a simple pill before IVF double baby hopes for endometriosis patients?
NCT ID NCT06375811
First seen Jun 06, 2026 · Last updated Jun 16, 2026 · Updated 2 times
Summary
This study tests whether taking an oral GnRH antagonist before IVF can improve the chance of a live birth for women with endometriosis. About 97 women will either receive the drug or no pre-treatment before their IVF cycle. The goal is to see if this approach leads to more successful pregnancies.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ENDOMETRIOSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Duke Fertility
Morrisville, North Carolina, 27560, United States
-
Johns Hopkins, Division of Reproductive Science and Women's Health Research
Baltimore, Maryland, 21205, United States
-
Northwestern University Department of Obstetrics and Gynecology
Chicago, Illinois, 60611, United States
-
University of Colorado Department of Obstetrics & Gynecology
Aurora, Colorado, 80045, United States
-
Yale School of Medicine Dept.of Ob/Gyn & Reproductive Sciences
New Haven, Connecticut, 06520, United States
Conditions
Explore the condition pages connected to this study.